400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2024-12-09
神经外周疗法开发商
医疗器械
治疗设备
Nexus NeuroTech Ventures;
Nexus NeuroTech Ventures;
Action Potential Venture Capital;
Action Potential Venture Capital;
Johnson & Johnson;
Lightstone Ventures;
GV;
OSF Ventures;
Ascension Ventures;
Triventures;
Reimagined Ventures;
PEAK6;
Lux Capital
2023-04-25
免疫疗法开发商
医药研发/制造
化学&生物药
Bill and Melinda Gates Foundation;
Bill and Melinda Gates Foundation;
AXA IM Alts;
AXA IM Alts;
Seventure Partners;
QUAD;
辉瑞;
Revelation Partners;
Atlantic Neptune;
Reimagined Ventures;
PEAK6;
Hambro Perks;
K2 HealthVentures;
Skyviews Life Science;
AMR Action Fund;
Korea Investment Partners;
Korea Investment&Securities;
PureTech Health
2021-11-09
细胞工程平台研发商
医药研发/制造
AI+制药
Section 32;
Section 32;
Debiopharm Innovation Fund;
Debiopharm Innovation Fund;
Reimagined Ventures;
dRx Capital;
TDK Ventures;
Elementum;
PEAK6;
Sands Capital Ventures
2021-06-17
全球性制药商
医药研发/制造
化学&生物药
2020-11-25
蛋白组学数据研发商
医药研发/制造
化学&生物药
Casdin Capital;
Casdin Capital;
T. Rowe Price;
T. Rowe Price;
Blue Water Life Science Fund;
Soleus Capital;
Mossrock Capital;
Monashee Investment Management;
Reimagined Ventures;
Madryn Asset Management;
Foresite Capital;
Farallon Capital Management
2020-08-20
高性能手持式超声平台和AI开发商
医疗器械
成像器械
Applied Ventures;
Applied Ventures;
Intel Capital;
Intel Capital;
Solasta Ventures;
Reimagined Ventures;
TDK Ventures;
Action Potential Venture Capital
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10